The Role of Staging Laparoscopy in Primary Gall Bladder Cancer—An Analysis of 409 Patients

2013 ◽  
Vol 258 (2) ◽  
pp. 318-323 ◽  
Author(s):  
Anil K. Agarwal ◽  
Raja Kalayarasan ◽  
Amit Javed ◽  
Nikhil Gupta ◽  
Hirdaya H. Nag
Keyword(s):  
Bladder Cancer ◽  
Gall Bladder ◽  
Staging Laparoscopy ◽  
Gall Bladder Cancer

Role of Combination Chemotherapy with 5-Fluorouracil, Cisplatin and Paclitaxel for Advanced Gall Bladder Cancer

2014 ◽  
Vol 05 (03) ◽  
pp. 246-252 ◽  
Author(s):  
Mumtaz Ahmad Ansari ◽  
Satyendra K. Tiwary ◽  
Uday Pratap Shahi ◽  
Vijay K. Shukla
Keyword(s):  
Bladder Cancer ◽  
Gall Bladder ◽  
Combination Chemotherapy ◽  
Gall Bladder Cancer ◽  
Advanced Gall Bladder Cancer

The role of H. pylori infection in gall bladder cancer: clinicopathological study

Tumor Biology ◽  
2015 ◽  
Vol 36 (9) ◽  
pp. 7093-7098 ◽  
Author(s):  
Ehsan Hassan Hassan ◽  
Shawkat S. Gerges ◽  
Kamal A. El-Atrebi ◽  
Hala T. El-Bassyouni
Keyword(s):  
Bladder Cancer ◽  
Gall Bladder ◽  
Gall Bladder Cancer ◽  
Clinicopathological Study ◽  
H Pylori

scholarly journals The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells

2000 ◽  
Vol 21 (7) ◽  
pp. 1403-1409 ◽  
Author(s):  
Erik M. Grossman ◽  
Walter E. Longo ◽  
Ninder Panesar ◽  
John E. Mazuski ◽  
Donald L. Kaminski
Keyword(s):  
Bladder Cancer ◽  
Gall Bladder ◽  
Cancer Cells ◽  
Gall Bladder Cancer ◽  
Bladder Cancer Cells

scholarly journals Role of PETCT in locally advanced gall bladder cancer

HPB ◽  
2020 ◽  
Vol 22 ◽  
pp. S365-S366
Author(s):  
A. Chaturvedi ◽  
D. Niyogi ◽  
A. Gupta ◽  
S. Patkar ◽  
R. Engineer ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Gall Bladder ◽  
Locally Advanced ◽  
Gall Bladder Cancer ◽  
Advanced Gall Bladder Cancer

scholarly journals Gallbladder Cancer: A Hospital Based Study

2017 ◽  
Vol 15 (2) ◽  
pp. 2-5
Author(s):  
Anup Sharma ◽  
P Thapa ◽  
A Dhakal
Keyword(s):  
Bladder Cancer ◽  
Gall Bladder ◽  
Metastatic Disease ◽  
Advanced Disease ◽  
Staging Laparoscopy ◽  
Gall Bladder Cancer ◽  
Common Symptom ◽  
Gastrointestinal Malignancies ◽  
Female Ratio ◽  
Number Of Patients

Introduction: Gallbladder carcinoma (GBC) is the commonest cancer of the biliary tree and the most frequent cause of death from biliary malignancies. The overall resection rates at presentation range from 10%-30% only. Therefore, a large number of patients are inoperable with overall survival of only 6-8 months. Palliation of the pain, jaundice, pruritus is a big challenge in patients with advanced disease. Methods: A prospective cross sectional study of patients with GBC during the period of October 2014 to September 2017 at Nepalgunj Medical College and Teaching Hospital, Kohalpur, department of surgery. Results: There were 216 cases of gastrointestinal malignancies with 54(25%) GBC. There was female (75.92%) preponderance with a male to female ratio of 1:3.15. The mean age was 61.41±12.18. The most common symptom at presentation was pain in a right upper abdomen (87.03%) followed by abdominal lump (41.23%) and surgical jaundice (18.51%). Fundus (70.37%) was the most common site of involvement followed by body (5.55%) and neck (24.05%). Gall stone was associated in 44 (81.48%) patients. Only 7 (12.96%) patients had localized GBC, 25 (46.29%) patients had locally advanced disease and 22 (40.74%) had metastatic disease. Liver was the commonest site of metastatis followed by peritoneum and two patients had left supraclavicular lymph node metastatis. There were two (3.72%) incidental gall bladder cancer after laparoscopic cholecystectomy. 13 (24.07%) patients were operated with intention of radical cholecystectomy but only six (46.15%) patient could undergo radical resection. Staging laparoscopy was done in all patients except for incidental gall bladder cancer. Metastatic disease was identified in 3 (23.07%) on staging laparoscopy. In eight (61.33%) among 13 patients the disease was unresectable. The most common histology was adenocarcinoma and most common stage was stage III and stage IV when both operated and non-operated groups were combined. Conclusions: GBC was the commonest gastrointestinal tract cancer with a female preponderance. A majority of patients were inoperable at presentation with pain in abdomen being the most common symptom. Surgery although is the main stay of treatment is not possible in many.

Defining the Role of Adjuvant Therapy: Cholangiocarcinoma and Gall Bladder Cancer

2014 ◽  
Vol 24 (2) ◽  
pp. 94-104 ◽  
Author(s):  
Terence M. Williams ◽  
Lonika Majithia ◽  
Samuel J. Wang ◽  
Charles R. Thomas
Keyword(s):  
Bladder Cancer ◽  
Adjuvant Therapy ◽  
Gall Bladder ◽  
Gall Bladder Cancer

The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells

2000 ◽  
Vol 21 (7) ◽  
pp. 1403-1409 ◽  
Author(s):  
Erik M. Grossman ◽  
Walter E. Longo ◽  
Ninder Panesar ◽  
John E. Mazuski ◽  
Donald L. Kaminski
Keyword(s):  
Bladder Cancer ◽  
Gall Bladder ◽  
Cancer Cells ◽  
Gall Bladder Cancer ◽  
Bladder Cancer Cells

scholarly journals Functional Role of MicroRNA‐200 Family in Human Gall Bladder Cancer Stem Cells

2015 ◽  
Vol 29 (S1) ◽  
Author(s):  
Fanyin Meng ◽  
Heather Francis ◽  
Yuyan Han ◽  
Shannon Glaser ◽  
Gianfranco Alpini
Keyword(s):  
Stem Cells ◽  
Bladder Cancer ◽  
Cancer Stem Cells ◽  
Gall Bladder ◽  
Functional Role ◽  
Gall Bladder Cancer

Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer

2019 ◽  
Vol 23 (11) ◽  
pp. 2232-2238
Author(s):  
Abhay K. Kattepur ◽  
Shraddha Patkar ◽  
Mahesh Goel ◽  
Anant Ramaswamy ◽  
Vikas Ostwal
Keyword(s):  
Bladder Cancer ◽  
Adjuvant Chemotherapy ◽  
Gall Bladder ◽  
Gall Bladder Cancer
Sign in / Sign up

Export Citation Format

Share Document